We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

2 hedge funds and large institutions have $2.75M invested in Allergan plc in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

856% more capital invested

Capital invested by funds: $287K → $2.75M (+$2.46M)

33% less funds holding

Funds holding: 32 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AGN Hedge Fund Activity: Q1 2021 in Review

2 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2021, worth a combined $2.75M — up 856% from $287K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of AGN and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Associated Banc-Corp, opening a new position worth an estimated $2.75M. The largest seller was Cornercap Investment Counsel, exiting entirely with an estimated $241K sold.

  • 2 institutional investors held Allergan plc (AGN) as of Q1 2021, down from 3 in Q4 2020.
  • Funds reported $2.75M of Allergan plc stock for Q1 2021, up 856% quarter-over-quarter.
  • 1 fund opened new Allergan plc positions in Q1 2021 and 2 closed out, a net change of -1 holder.
  • The largest Allergan plc buyer in Q1 2021 was Associated Banc-Corp, an estimated $2.75M added.
  • The largest Allergan plc seller in Q1 2021 was Cornercap Investment Counsel, an estimated $241K sold.

Based on aggregated 13F filings for Q1 2021.